Scientists identified the enzyme RimJ as responsible for adding an acetyl group to the front end of thymosin alpha-1 when the peptide is produced in E. coli bacteria. By co-expressing RimJ, they achieved full acetylation of the recombinant peptide, solving a long-standing challenge in producing the properly modified form of this immune-stimulating drug in bacterial systems.
Fang, Hongqing; Zhang, Xu; Shen, Lin; Si, Xinxi; Ren, Yuantao; Dai, Hongmei; Li, Shulong; Zhou, Changlin; Chen, Huipeng